XML 47 R31.htm IDEA: XBRL DOCUMENT v3.25.1

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Estimated Values of Stock Option Grants Valuation Assumptions

 Schedule of Estimated Values of Stock Option Grants Valuation Assumptions

		Grant Date August 16, 2024				Grant Date September 4, 2024
Risk-free interest rate			3.77	%			3.61	%
Weighted average expected term			5 years				6 years
Expected volatility			100.97	%			101.00	%
Expected dividend yield			0.00	%			0.00	%

Schedule of Stock Options Activity

A summary of stock option activity during the years ended December 31, 2024 and 2023 is as follows:

 Schedule of Stock Options Activity

										Weighted-
						Weighted-				Average
						Average				Remaining				Aggregate
		Shares				Exercise				Contractual				Intrinsic
		Under Option				Price				Life				Value
Outstanding at January 1, 2024			357,887			$	5.69				8 years			$	-
Granted			50,500				9.16
Exercised			(29,976	)			5.07
Forfeited			(4,000	)			4.63								-
Outstanding at December 31, 2024			374,411			$	6.22				7 years			$	-
Exercisable at December 31, 2024			284,912			$	6.06				7 years			$	-

										Weighted-
						Weighted-				Average
						Average				Remaining				Aggregate
		Shares				Exercise				Contractual				Intrinsic
		Under Option				Price				Life				Value
Outstanding at January 1, 2023			365,447			$	5.89				8 years			$	19,200
Forfeited			(7,560	)			15.34								(19,200	)
Outstanding at December 31, 2023			357,887			$	5.69				8 years			$	-
Exercisable at December 31, 2023			186,594			$	5.60				7 years			$	-

Schedule of Stock Options Grant

The following represent grants of stock options, including the fair value recognized or to be recognized over the requisite service period:

 Schedule of Stock Options Grant

Grant date		Shares granted (canceled)				Exercise price				Date fully vested		Fair value
February 10, 2016			4,200			$	48.00			February 10, 2020		$	174,748
December 6, 2016			2,000				38.00			December 6, 2020			63,937
September 25, 2017			15,000				15.00			September 25, 2019			194,149
September 25, 2017			10,000				19.00			September 25, 2019			126,862
January 30, 2019			250				45.00			January 30, 2019			885
March 11, 2019			(33,200	)			-			-			-
March 11, 2019			33,200				6.50			December 6, 2020			24,898	(1)
March 11, 2019			10,100				6.50			March 11, 2023			44,591
September 2, 2020			99,000				4.00			September 2, 2024			327,181
April 14, 2022			220,587				6.08			April 14, 2025			1,152,470
August 16, 2024			36,000				8.78			August 16, 2024			241,735
September 4, 2024			14,500				10.12			September 4, 2027			118,347

(1) Represents incremental fair value of replacement shares compared to canceled shares.

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration